Showing results (31-40 of 187) with videos related to
Sort By:
Pageof 19
Pharmacogenomics|December 17, 2013
Pharmacogenetics of taste: turning bitter pills sweet?Mariëlle J Nagtegaal, Jesse J Swen, Lidwien M Hanff, et al.Anesthesia and Analgesia|December 1, 1989
Interaction between nondepolarizing neuromuscular blocking agents and inhalational anestheticsJ Swen, O M Rashkovsky, J M Ket, et al.Clinical Pharmacology and Therapeutics|January 23, 2014
Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencingH-J Guchelaar, H Gelderblom, T van der Straaten, et al.Pharmacogenomics|December 3, 2010
Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitusJesse J Swen, Judith A M Wessels, Annemarie Krabben, et al.Frontiers in Pharmacology|August 7, 2024
Pharmacogenetic educational needs and the role of pharmacogenetics in primary care: a focus group study with multiple perspectivesMaaike E Ferwerda, Jessica A Wright, Razan M El Melik, et al.Cancers|December 23, 2023
IGF1 and Insulin Receptor Single Nucleotide Variants Associated with Response in HER2-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without a Fasting Mimicking Diet (BOOG 2013-04 DIRECT Trial)Nadia de Gruil, Stefan Böhringer, Stefanie de Groot, et al.Therapeutic Advances in Rare Disease|November 13, 2023
Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington's disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogeneticsStephanie Feleus, Maaike van der Lee, Jesse J Swen, et al.Cancer Chemotherapy and Pharmacology|July 13, 2026
Design characteristics of mass balance studies conducted for protein kinase inhibitorsBenthe Riechelman, Ramon Bolks, Thijs H Oude Munnink, et al.British Journal of Clinical Pharmacology|June 20, 2023
Pharmacokinetic profile of irinotecan in patients with chronic kidney disease: Two cases and literature reviewChang Yue Chui, Dirk Jan A R Moes, Stijn L W Koolen, et al.British Journal of Clinical Pharmacology|April 29, 2022
A systematic review on disease-drug-drug interactions with immunomodulating drugs: A critical appraisal of risk assessment and drug labellingLaura M de Jong, Sylvia D Klomp, Nicoline Treijtel, et al.Pageof 19